nodes	percent_of_prediction	percent_of_DWPC	metapath
Salicylic acid—L-Phenylalanine—Melphalan—ovarian cancer	0.375	1	CrCrCtD
Salicylic acid—ABCB1—ovarian cancer	0.269	1	CbGaD
Salicylic acid—SLC22A7—Docetaxel—ovarian cancer	0.0697	0.362	CbGbCtD
Salicylic acid—ABCB1—Topotecan—ovarian cancer	0.0369	0.191	CbGbCtD
Salicylic acid—ABCB1—Vinorelbine—ovarian cancer	0.026	0.135	CbGbCtD
Salicylic acid—CYP2C9—Paclitaxel—ovarian cancer	0.0188	0.0977	CbGbCtD
Salicylic acid—ABCB1—Paclitaxel—ovarian cancer	0.0183	0.0948	CbGbCtD
Salicylic acid—ABCB1—Docetaxel—ovarian cancer	0.0132	0.0685	CbGbCtD
Salicylic acid—ABCB1—Doxorubicin—ovarian cancer	0.00985	0.0511	CbGbCtD
Salicylic acid—PTGS2—ovarian follicle—ovarian cancer	0.00543	0.132	CbGeAlD
Salicylic acid—PTGS1—oviduct—ovarian cancer	0.0025	0.0606	CbGeAlD
Salicylic acid—Heartburn—Topotecan—ovarian cancer	0.00233	0.0253	CcSEcCtD
Salicylic acid—Anorexia—Altretamine—ovarian cancer	0.00172	0.0187	CcSEcCtD
Salicylic acid—Duodenal ulcer—Docetaxel—ovarian cancer	0.00162	0.0176	CcSEcCtD
Salicylic acid—Acetylsalicylic acid—TP53—ovarian cancer	0.00158	0.857	CrCbGaD
Salicylic acid—Decreased appetite—Altretamine—ovarian cancer	0.00157	0.0171	CcSEcCtD
Salicylic acid—Skin exfoliation—Melphalan—ovarian cancer	0.0015	0.0163	CcSEcCtD
Salicylic acid—Hearing impaired—Vinorelbine—ovarian cancer	0.00144	0.0156	CcSEcCtD
Salicylic acid—SLC16A1—epithelium—ovarian cancer	0.0014	0.0339	CbGeAlD
Salicylic acid—SLC22A11—female reproductive system—ovarian cancer	0.00139	0.0338	CbGeAlD
Salicylic acid—SLC16A1—decidua—ovarian cancer	0.00132	0.0321	CbGeAlD
Salicylic acid—Skin exfoliation—Vinorelbine—ovarian cancer	0.00131	0.0142	CcSEcCtD
Salicylic acid—Oesophagitis—Vinorelbine—ovarian cancer	0.00125	0.0136	CcSEcCtD
Salicylic acid—SLC16A1—endometrium—ovarian cancer	0.00125	0.0304	CbGeAlD
Salicylic acid—Dizziness—Altretamine—ovarian cancer	0.0012	0.013	CcSEcCtD
Salicylic acid—Lethargy—Topotecan—ovarian cancer	0.00119	0.0129	CcSEcCtD
Salicylic acid—SLC16A1—gonad—ovarian cancer	0.00116	0.0282	CbGeAlD
Salicylic acid—SLC16A1—uterus—ovarian cancer	0.00115	0.028	CbGeAlD
Salicylic acid—Vomiting—Altretamine—ovarian cancer	0.00115	0.0125	CcSEcCtD
Salicylic acid—Heartburn—Docetaxel—ovarian cancer	0.00114	0.0123	CcSEcCtD
Salicylic acid—SLCO2B1—decidua—ovarian cancer	0.00114	0.0276	CbGeAlD
Salicylic acid—Burning sensation—Docetaxel—ovarian cancer	0.00113	0.0122	CcSEcCtD
Salicylic acid—Deafness—Vinorelbine—ovarian cancer	0.00111	0.0121	CcSEcCtD
Salicylic acid—SLC22A7—testis—ovarian cancer	0.0011	0.0266	CbGeAlD
Salicylic acid—Nausea—Altretamine—ovarian cancer	0.00107	0.0117	CcSEcCtD
Salicylic acid—Pain—Carboplatin—ovarian cancer	0.00107	0.0116	CcSEcCtD
Salicylic acid—SLC16A1—female reproductive system—ovarian cancer	0.00104	0.0252	CbGeAlD
Salicylic acid—Lethargy—Vinorelbine—ovarian cancer	0.00102	0.011	CcSEcCtD
Salicylic acid—SLCO2B1—uterus—ovarian cancer	0.000993	0.0241	CbGeAlD
Salicylic acid—Hearing impaired—Paclitaxel—ovarian cancer	0.000969	0.0105	CcSEcCtD
Salicylic acid—SLC16A1—female gonad—ovarian cancer	0.000944	0.0229	CbGeAlD
Salicylic acid—Weight increased—Topotecan—ovarian cancer	0.000915	0.00994	CcSEcCtD
Salicylic acid—Gastric ulcer—Epirubicin—ovarian cancer	0.000907	0.00985	CcSEcCtD
Salicylic acid—Hallucination—Chlorambucil—ovarian cancer	0.0009	0.00977	CcSEcCtD
Salicylic acid—SLCO2B1—female reproductive system—ovarian cancer	0.000893	0.0217	CbGeAlD
Salicylic acid—Skin exfoliation—Paclitaxel—ovarian cancer	0.000881	0.00956	CcSEcCtD
Salicylic acid—Erythema multiforme—Chlorambucil—ovarian cancer	0.000855	0.00929	CcSEcCtD
Salicylic acid—Epistaxis—Topotecan—ovarian cancer	0.000846	0.00919	CcSEcCtD
Salicylic acid—Oesophagitis—Paclitaxel—ovarian cancer	0.000843	0.00915	CcSEcCtD
Salicylic acid—Gastric ulcer—Doxorubicin—ovarian cancer	0.00084	0.00912	CcSEcCtD
Salicylic acid—SLC16A1—testis—ovarian cancer	0.000837	0.0203	CbGeAlD
Salicylic acid—Lightheadedness—Paclitaxel—ovarian cancer	0.000825	0.00896	CcSEcCtD
Salicylic acid—Hearing impaired—Docetaxel—ovarian cancer	0.000821	0.00892	CcSEcCtD
Salicylic acid—SLCO2B1—female gonad—ovarian cancer	0.000812	0.0197	CbGeAlD
Salicylic acid—Hepatitis—Melphalan—ovarian cancer	0.000788	0.00856	CcSEcCtD
Salicylic acid—PTGS2—myometrium—ovarian cancer	0.000763	0.0185	CbGeAlD
Salicylic acid—Burning sensation—Epirubicin—ovarian cancer	0.000759	0.00824	CcSEcCtD
Salicylic acid—Deafness—Paclitaxel—ovarian cancer	0.000749	0.00813	CcSEcCtD
Salicylic acid—Skin exfoliation—Docetaxel—ovarian cancer	0.000746	0.00811	CcSEcCtD
Salicylic acid—PTGS2—embryo—ovarian cancer	0.000734	0.0178	CbGeAlD
Salicylic acid—SLCO2B1—testis—ovarian cancer	0.00072	0.0175	CbGeAlD
Salicylic acid—Oesophagitis—Docetaxel—ovarian cancer	0.000714	0.00776	CcSEcCtD
Salicylic acid—Burning sensation—Doxorubicin—ovarian cancer	0.000702	0.00763	CcSEcCtD
Salicylic acid—Lightheadedness—Docetaxel—ovarian cancer	0.0007	0.0076	CcSEcCtD
Salicylic acid—Lethargy—Paclitaxel—ovarian cancer	0.000683	0.00742	CcSEcCtD
Salicylic acid—ALB—testis—ovarian cancer	0.000659	0.016	CbGeAlD
Salicylic acid—Stinging—Epirubicin—ovarian cancer	0.000651	0.00707	CcSEcCtD
Salicylic acid—Confusional state—Chlorambucil—ovarian cancer	0.000648	0.00704	CcSEcCtD
Salicylic acid—Deafness—Docetaxel—ovarian cancer	0.000634	0.00689	CcSEcCtD
Salicylic acid—PTGS1—epithelium—ovarian cancer	0.000627	0.0152	CbGeAlD
Salicylic acid—PTGS1—uterine cervix—ovarian cancer	0.000621	0.0151	CbGeAlD
Salicylic acid—Anorexia—Chlorambucil—ovarian cancer	0.000612	0.00665	CcSEcCtD
Salicylic acid—Abdominal pain upper—Paclitaxel—ovarian cancer	0.000612	0.00664	CcSEcCtD
Salicylic acid—SLC16A1—lymph node—ovarian cancer	0.000607	0.0147	CbGeAlD
Salicylic acid—Stinging—Doxorubicin—ovarian cancer	0.000602	0.00654	CcSEcCtD
Salicylic acid—Erythema—Vinorelbine—ovarian cancer	0.0006	0.00651	CcSEcCtD
Salicylic acid—PTGS2—epithelium—ovarian cancer	0.000599	0.0146	CbGeAlD
Salicylic acid—PTGS2—uterine cervix—ovarian cancer	0.000594	0.0144	CbGeAlD
Salicylic acid—Lethargy—Docetaxel—ovarian cancer	0.000579	0.00629	CcSEcCtD
Salicylic acid—Dyspepsia—Chlorambucil—ovarian cancer	0.000566	0.00614	CcSEcCtD
Salicylic acid—PTGS1—endometrium—ovarian cancer	0.000562	0.0137	CbGeAlD
Salicylic acid—Oedema—Melphalan—ovarian cancer	0.00056	0.00608	CcSEcCtD
Salicylic acid—Decreased appetite—Chlorambucil—ovarian cancer	0.000559	0.00607	CcSEcCtD
Salicylic acid—Pain—Chlorambucil—ovarian cancer	0.000549	0.00597	CcSEcCtD
Salicylic acid—Anorexia—Topotecan—ovarian cancer	0.000545	0.00592	CcSEcCtD
Salicylic acid—PTGS2—endometrium—ovarian cancer	0.000537	0.013	CbGeAlD
Salicylic acid—Anorexia—Melphalan—ovarian cancer	0.000534	0.0058	CcSEcCtD
Salicylic acid—Feeling abnormal—Chlorambucil—ovarian cancer	0.000529	0.00575	CcSEcCtD
Salicylic acid—Weight increased—Paclitaxel—ovarian cancer	0.000527	0.00572	CcSEcCtD
Salicylic acid—SLCO2B1—lymph node—ovarian cancer	0.000522	0.0127	CbGeAlD
Salicylic acid—Abdominal pain upper—Docetaxel—ovarian cancer	0.000518	0.00563	CcSEcCtD
Salicylic acid—PTGS1—uterus—ovarian cancer	0.000518	0.0126	CbGeAlD
Salicylic acid—Urticaria—Chlorambucil—ovarian cancer	0.00051	0.00554	CcSEcCtD
Salicylic acid—CYP2C9—female reproductive system—ovarian cancer	0.00051	0.0124	CbGeAlD
Salicylic acid—Skin exfoliation—Epirubicin—ovarian cancer	0.000503	0.00547	CcSEcCtD
Salicylic acid—Dyspepsia—Topotecan—ovarian cancer	0.000503	0.00547	CcSEcCtD
Salicylic acid—Decreased appetite—Topotecan—ovarian cancer	0.000497	0.0054	CcSEcCtD
Salicylic acid—PTGS2—uterus—ovarian cancer	0.000495	0.012	CbGeAlD
Salicylic acid—Dyspepsia—Melphalan—ovarian cancer	0.000493	0.00535	CcSEcCtD
Salicylic acid—Pain—Topotecan—ovarian cancer	0.000489	0.00531	CcSEcCtD
Salicylic acid—Constipation—Topotecan—ovarian cancer	0.000489	0.00531	CcSEcCtD
Salicylic acid—Decreased appetite—Melphalan—ovarian cancer	0.000487	0.00529	CcSEcCtD
Salicylic acid—Epistaxis—Paclitaxel—ovarian cancer	0.000487	0.00529	CcSEcCtD
Salicylic acid—Oesophagitis—Epirubicin—ovarian cancer	0.000482	0.00523	CcSEcCtD
Salicylic acid—Pain—Melphalan—ovarian cancer	0.000479	0.0052	CcSEcCtD
Salicylic acid—ALB—lymph node—ovarian cancer	0.000478	0.0116	CbGeAlD
Salicylic acid—Ecchymosis—Epirubicin—ovarian cancer	0.000477	0.00518	CcSEcCtD
Salicylic acid—ABCB1—myometrium—ovarian cancer	0.000472	0.0115	CbGeAlD
Salicylic acid—Feeling abnormal—Topotecan—ovarian cancer	0.000471	0.00512	CcSEcCtD
Salicylic acid—Anorexia—Vinorelbine—ovarian cancer	0.000466	0.00506	CcSEcCtD
Salicylic acid—Skin exfoliation—Doxorubicin—ovarian cancer	0.000466	0.00506	CcSEcCtD
Salicylic acid—PTGS1—female reproductive system—ovarian cancer	0.000465	0.0113	CbGeAlD
Salicylic acid—Pruritus—Chlorambucil—ovarian cancer	0.000455	0.00494	CcSEcCtD
Salicylic acid—Urticaria—Topotecan—ovarian cancer	0.000454	0.00493	CcSEcCtD
Salicylic acid—ABCB1—embryo—ovarian cancer	0.000454	0.011	CbGeAlD
Salicylic acid—Weight increased—Docetaxel—ovarian cancer	0.000446	0.00485	CcSEcCtD
Salicylic acid—Oesophagitis—Doxorubicin—ovarian cancer	0.000446	0.00484	CcSEcCtD
Salicylic acid—Urticaria—Melphalan—ovarian cancer	0.000445	0.00483	CcSEcCtD
Salicylic acid—PTGS2—female reproductive system—ovarian cancer	0.000445	0.0108	CbGeAlD
Salicylic acid—Ecchymosis—Doxorubicin—ovarian cancer	0.000441	0.00479	CcSEcCtD
Salicylic acid—Diarrhoea—Chlorambucil—ovarian cancer	0.00044	0.00477	CcSEcCtD
Salicylic acid—Erythema multiforme—Paclitaxel—ovarian cancer	0.000438	0.00476	CcSEcCtD
Salicylic acid—Tinnitus—Paclitaxel—ovarian cancer	0.000432	0.00469	CcSEcCtD
Salicylic acid—Decreased appetite—Vinorelbine—ovarian cancer	0.000425	0.00462	CcSEcCtD
Salicylic acid—PTGS1—female gonad—ovarian cancer	0.000424	0.0103	CbGeAlD
Salicylic acid—PTGS1—vagina—ovarian cancer	0.000421	0.0102	CbGeAlD
Salicylic acid—PTGS2—bone marrow—ovarian cancer	0.00042	0.0102	CbGeAlD
Salicylic acid—Pain—Vinorelbine—ovarian cancer	0.000418	0.00454	CcSEcCtD
Salicylic acid—Constipation—Vinorelbine—ovarian cancer	0.000418	0.00454	CcSEcCtD
Salicylic acid—Epistaxis—Docetaxel—ovarian cancer	0.000413	0.00448	CcSEcCtD
Salicylic acid—Vomiting—Chlorambucil—ovarian cancer	0.000409	0.00444	CcSEcCtD
Salicylic acid—PTGS2—female gonad—ovarian cancer	0.000405	0.00984	CbGeAlD
Salicylic acid—Pruritus—Topotecan—ovarian cancer	0.000405	0.00439	CcSEcCtD
Salicylic acid—Erythema—Paclitaxel—ovarian cancer	0.000403	0.00438	CcSEcCtD
Salicylic acid—Feeling abnormal—Vinorelbine—ovarian cancer	0.000403	0.00438	CcSEcCtD
Salicylic acid—PTGS2—vagina—ovarian cancer	0.000402	0.00978	CbGeAlD
Salicylic acid—Pruritus—Melphalan—ovarian cancer	0.000396	0.0043	CcSEcCtD
Salicylic acid—Dysgeusia—Paclitaxel—ovarian cancer	0.000395	0.00429	CcSEcCtD
Salicylic acid—Hepatitis—Docetaxel—ovarian cancer	0.000393	0.00426	CcSEcCtD
Salicylic acid—Diarrhoea—Topotecan—ovarian cancer	0.000391	0.00425	CcSEcCtD
Salicylic acid—Lethargy—Epirubicin—ovarian cancer	0.000391	0.00424	CcSEcCtD
Salicylic acid—Urticaria—Vinorelbine—ovarian cancer	0.000389	0.00422	CcSEcCtD
Salicylic acid—Diarrhoea—Melphalan—ovarian cancer	0.000383	0.00416	CcSEcCtD
Salicylic acid—Nausea—Chlorambucil—ovarian cancer	0.000382	0.00414	CcSEcCtD
Salicylic acid—Dizziness—Topotecan—ovarian cancer	0.000378	0.00411	CcSEcCtD
Salicylic acid—PTGS1—testis—ovarian cancer	0.000376	0.00913	CbGeAlD
Salicylic acid—Erythema multiforme—Docetaxel—ovarian cancer	0.000371	0.00403	CcSEcCtD
Salicylic acid—ABCB1—epithelium—ovarian cancer	0.00037	0.009	CbGeAlD
Salicylic acid—ABCB1—uterine cervix—ovarian cancer	0.000367	0.00892	CbGeAlD
Salicylic acid—Vomiting—Topotecan—ovarian cancer	0.000364	0.00395	CcSEcCtD
Salicylic acid—Lethargy—Doxorubicin—ovarian cancer	0.000361	0.00393	CcSEcCtD
Salicylic acid—Rash—Topotecan—ovarian cancer	0.000361	0.00392	CcSEcCtD
Salicylic acid—Dermatitis—Topotecan—ovarian cancer	0.00036	0.00391	CcSEcCtD
Salicylic acid—Headache—Topotecan—ovarian cancer	0.000358	0.00389	CcSEcCtD
Salicylic acid—Vomiting—Melphalan—ovarian cancer	0.000356	0.00387	CcSEcCtD
Salicylic acid—Rash—Melphalan—ovarian cancer	0.000353	0.00383	CcSEcCtD
Salicylic acid—Dermatitis—Melphalan—ovarian cancer	0.000353	0.00383	CcSEcCtD
Salicylic acid—ABCB1—decidua—ovarian cancer	0.00035	0.0085	CbGeAlD
Salicylic acid—Abdominal pain upper—Epirubicin—ovarian cancer	0.00035	0.0038	CcSEcCtD
Salicylic acid—Pruritus—Vinorelbine—ovarian cancer	0.000346	0.00376	CcSEcCtD
Salicylic acid—Erythema—Docetaxel—ovarian cancer	0.000342	0.00371	CcSEcCtD
Salicylic acid—Nausea—Topotecan—ovarian cancer	0.00034	0.00369	CcSEcCtD
Salicylic acid—Diarrhoea—Vinorelbine—ovarian cancer	0.000335	0.00364	CcSEcCtD
Salicylic acid—Dysgeusia—Docetaxel—ovarian cancer	0.000335	0.00363	CcSEcCtD
Salicylic acid—Nausea—Melphalan—ovarian cancer	0.000333	0.00361	CcSEcCtD
Salicylic acid—ABCB1—endometrium—ovarian cancer	0.000332	0.00807	CbGeAlD
Salicylic acid—Confusional state—Paclitaxel—ovarian cancer	0.000332	0.0036	CcSEcCtD
Salicylic acid—Asthma—Epirubicin—ovarian cancer	0.000331	0.00359	CcSEcCtD
Salicylic acid—Oedema—Paclitaxel—ovarian cancer	0.000329	0.00357	CcSEcCtD
Salicylic acid—Dizziness—Vinorelbine—ovarian cancer	0.000324	0.00351	CcSEcCtD
Salicylic acid—Abdominal pain upper—Doxorubicin—ovarian cancer	0.000324	0.00351	CcSEcCtD
Salicylic acid—Anorexia—Paclitaxel—ovarian cancer	0.000314	0.00341	CcSEcCtD
Salicylic acid—Vomiting—Vinorelbine—ovarian cancer	0.000311	0.00338	CcSEcCtD
Salicylic acid—Rash—Vinorelbine—ovarian cancer	0.000309	0.00335	CcSEcCtD
Salicylic acid—Dermatitis—Vinorelbine—ovarian cancer	0.000308	0.00335	CcSEcCtD
Salicylic acid—ABCB1—gonad—ovarian cancer	0.000308	0.00749	CbGeAlD
Salicylic acid—Headache—Vinorelbine—ovarian cancer	0.000307	0.00333	CcSEcCtD
Salicylic acid—Asthma—Doxorubicin—ovarian cancer	0.000306	0.00332	CcSEcCtD
Salicylic acid—ABCB1—uterus—ovarian cancer	0.000306	0.00744	CbGeAlD
Salicylic acid—Weight increased—Epirubicin—ovarian cancer	0.000301	0.00327	CcSEcCtD
Salicylic acid—Drowsiness—Epirubicin—ovarian cancer	0.000295	0.0032	CcSEcCtD
Salicylic acid—Somnolence—Paclitaxel—ovarian cancer	0.000293	0.00318	CcSEcCtD
Salicylic acid—Nausea—Vinorelbine—ovarian cancer	0.000291	0.00316	CcSEcCtD
Salicylic acid—Dyspepsia—Paclitaxel—ovarian cancer	0.00029	0.00315	CcSEcCtD
Salicylic acid—Decreased appetite—Paclitaxel—ovarian cancer	0.000286	0.00311	CcSEcCtD
Salicylic acid—Pain—Paclitaxel—ovarian cancer	0.000281	0.00306	CcSEcCtD
Salicylic acid—Constipation—Paclitaxel—ovarian cancer	0.000281	0.00306	CcSEcCtD
Salicylic acid—Confusional state—Docetaxel—ovarian cancer	0.000281	0.00305	CcSEcCtD
Salicylic acid—Oedema—Docetaxel—ovarian cancer	0.000279	0.00303	CcSEcCtD
Salicylic acid—Weight increased—Doxorubicin—ovarian cancer	0.000279	0.00303	CcSEcCtD
Salicylic acid—Epistaxis—Epirubicin—ovarian cancer	0.000278	0.00302	CcSEcCtD
Salicylic acid—ABCB1—female reproductive system—ovarian cancer	0.000275	0.00669	CbGeAlD
Salicylic acid—Drowsiness—Doxorubicin—ovarian cancer	0.000273	0.00296	CcSEcCtD
Salicylic acid—PTGS1—lymph node—ovarian cancer	0.000272	0.00662	CbGeAlD
Salicylic acid—Feeling abnormal—Paclitaxel—ovarian cancer	0.000271	0.00295	CcSEcCtD
Salicylic acid—Anorexia—Docetaxel—ovarian cancer	0.000266	0.00289	CcSEcCtD
Salicylic acid—Hepatitis—Epirubicin—ovarian cancer	0.000265	0.00288	CcSEcCtD
Salicylic acid—Acetylsalicylic acid—ABCB1—ovarian cancer	0.000263	0.143	CrCbGaD
Salicylic acid—Urticaria—Paclitaxel—ovarian cancer	0.000261	0.00284	CcSEcCtD
Salicylic acid—PTGS2—lymph node—ovarian cancer	0.00026	0.00632	CbGeAlD
Salicylic acid—ABCB1—bone marrow—ovarian cancer	0.00026	0.00631	CbGeAlD
Salicylic acid—Epistaxis—Doxorubicin—ovarian cancer	0.000257	0.0028	CcSEcCtD
Salicylic acid—ABCB1—female gonad—ovarian cancer	0.00025	0.00608	CbGeAlD
Salicylic acid—Erythema multiforme—Epirubicin—ovarian cancer	0.00025	0.00272	CcSEcCtD
Salicylic acid—ABCB1—vagina—ovarian cancer	0.000249	0.00605	CbGeAlD
Salicylic acid—Somnolence—Docetaxel—ovarian cancer	0.000248	0.00269	CcSEcCtD
Salicylic acid—Tinnitus—Epirubicin—ovarian cancer	0.000247	0.00268	CcSEcCtD
Salicylic acid—Dyspepsia—Docetaxel—ovarian cancer	0.000246	0.00267	CcSEcCtD
Salicylic acid—Hepatitis—Doxorubicin—ovarian cancer	0.000245	0.00266	CcSEcCtD
Salicylic acid—Decreased appetite—Docetaxel—ovarian cancer	0.000242	0.00263	CcSEcCtD
Salicylic acid—Pain—Docetaxel—ovarian cancer	0.000239	0.00259	CcSEcCtD
Salicylic acid—Constipation—Docetaxel—ovarian cancer	0.000239	0.00259	CcSEcCtD
Salicylic acid—Pruritus—Paclitaxel—ovarian cancer	0.000233	0.00253	CcSEcCtD
Salicylic acid—Erythema multiforme—Doxorubicin—ovarian cancer	0.000232	0.00252	CcSEcCtD
Salicylic acid—Erythema—Epirubicin—ovarian cancer	0.000231	0.0025	CcSEcCtD
Salicylic acid—Feeling abnormal—Docetaxel—ovarian cancer	0.00023	0.0025	CcSEcCtD
Salicylic acid—Tinnitus—Doxorubicin—ovarian cancer	0.000228	0.00248	CcSEcCtD
Salicylic acid—Dysgeusia—Epirubicin—ovarian cancer	0.000226	0.00245	CcSEcCtD
Salicylic acid—Diarrhoea—Paclitaxel—ovarian cancer	0.000225	0.00245	CcSEcCtD
Salicylic acid—ABCB1—testis—ovarian cancer	0.000222	0.0054	CbGeAlD
Salicylic acid—Dizziness—Paclitaxel—ovarian cancer	0.000218	0.00236	CcSEcCtD
Salicylic acid—Erythema—Doxorubicin—ovarian cancer	0.000213	0.00232	CcSEcCtD
Salicylic acid—Vomiting—Paclitaxel—ovarian cancer	0.000209	0.00227	CcSEcCtD
Salicylic acid—Dysgeusia—Doxorubicin—ovarian cancer	0.000209	0.00227	CcSEcCtD
Salicylic acid—Rash—Paclitaxel—ovarian cancer	0.000208	0.00225	CcSEcCtD
Salicylic acid—Dermatitis—Paclitaxel—ovarian cancer	0.000207	0.00225	CcSEcCtD
Salicylic acid—Headache—Paclitaxel—ovarian cancer	0.000206	0.00224	CcSEcCtD
Salicylic acid—Pruritus—Docetaxel—ovarian cancer	0.000197	0.00214	CcSEcCtD
Salicylic acid—Nausea—Paclitaxel—ovarian cancer	0.000195	0.00212	CcSEcCtD
Salicylic acid—Diarrhoea—Docetaxel—ovarian cancer	0.000191	0.00207	CcSEcCtD
Salicylic acid—Confusional state—Epirubicin—ovarian cancer	0.00019	0.00206	CcSEcCtD
Salicylic acid—Oedema—Epirubicin—ovarian cancer	0.000188	0.00204	CcSEcCtD
Salicylic acid—Dizziness—Docetaxel—ovarian cancer	0.000184	0.002	CcSEcCtD
Salicylic acid—Anorexia—Epirubicin—ovarian cancer	0.000179	0.00195	CcSEcCtD
Salicylic acid—Vomiting—Docetaxel—ovarian cancer	0.000177	0.00193	CcSEcCtD
Salicylic acid—Rash—Docetaxel—ovarian cancer	0.000176	0.00191	CcSEcCtD
Salicylic acid—Dermatitis—Docetaxel—ovarian cancer	0.000176	0.00191	CcSEcCtD
Salicylic acid—Confusional state—Doxorubicin—ovarian cancer	0.000176	0.00191	CcSEcCtD
Salicylic acid—Headache—Docetaxel—ovarian cancer	0.000175	0.0019	CcSEcCtD
Salicylic acid—Oedema—Doxorubicin—ovarian cancer	0.000174	0.00189	CcSEcCtD
Salicylic acid—Somnolence—Epirubicin—ovarian cancer	0.000167	0.00182	CcSEcCtD
Salicylic acid—Anorexia—Doxorubicin—ovarian cancer	0.000166	0.0018	CcSEcCtD
Salicylic acid—Nausea—Docetaxel—ovarian cancer	0.000166	0.0018	CcSEcCtD
Salicylic acid—Dyspepsia—Epirubicin—ovarian cancer	0.000166	0.0018	CcSEcCtD
Salicylic acid—Decreased appetite—Epirubicin—ovarian cancer	0.000164	0.00178	CcSEcCtD
Salicylic acid—ABCB1—lymph node—ovarian cancer	0.000161	0.00391	CbGeAlD
Salicylic acid—Pain—Epirubicin—ovarian cancer	0.000161	0.00175	CcSEcCtD
Salicylic acid—Constipation—Epirubicin—ovarian cancer	0.000161	0.00175	CcSEcCtD
Salicylic acid—Feeling abnormal—Epirubicin—ovarian cancer	0.000155	0.00168	CcSEcCtD
Salicylic acid—Somnolence—Doxorubicin—ovarian cancer	0.000155	0.00168	CcSEcCtD
Salicylic acid—Dyspepsia—Doxorubicin—ovarian cancer	0.000153	0.00166	CcSEcCtD
Salicylic acid—Decreased appetite—Doxorubicin—ovarian cancer	0.000151	0.00164	CcSEcCtD
Salicylic acid—Urticaria—Epirubicin—ovarian cancer	0.000149	0.00162	CcSEcCtD
Salicylic acid—Pain—Doxorubicin—ovarian cancer	0.000149	0.00162	CcSEcCtD
Salicylic acid—Constipation—Doxorubicin—ovarian cancer	0.000149	0.00162	CcSEcCtD
Salicylic acid—Feeling abnormal—Doxorubicin—ovarian cancer	0.000143	0.00156	CcSEcCtD
Salicylic acid—Urticaria—Doxorubicin—ovarian cancer	0.000138	0.0015	CcSEcCtD
Salicylic acid—Pruritus—Epirubicin—ovarian cancer	0.000133	0.00145	CcSEcCtD
Salicylic acid—Diarrhoea—Epirubicin—ovarian cancer	0.000129	0.0014	CcSEcCtD
Salicylic acid—Dizziness—Epirubicin—ovarian cancer	0.000124	0.00135	CcSEcCtD
Salicylic acid—Pruritus—Doxorubicin—ovarian cancer	0.000123	0.00134	CcSEcCtD
Salicylic acid—Vomiting—Epirubicin—ovarian cancer	0.00012	0.0013	CcSEcCtD
Salicylic acid—Diarrhoea—Doxorubicin—ovarian cancer	0.000119	0.00129	CcSEcCtD
Salicylic acid—Rash—Epirubicin—ovarian cancer	0.000119	0.00129	CcSEcCtD
Salicylic acid—Dermatitis—Epirubicin—ovarian cancer	0.000119	0.00129	CcSEcCtD
Salicylic acid—Headache—Epirubicin—ovarian cancer	0.000118	0.00128	CcSEcCtD
Salicylic acid—Dizziness—Doxorubicin—ovarian cancer	0.000115	0.00125	CcSEcCtD
Salicylic acid—Nausea—Epirubicin—ovarian cancer	0.000112	0.00121	CcSEcCtD
Salicylic acid—Vomiting—Doxorubicin—ovarian cancer	0.000111	0.0012	CcSEcCtD
Salicylic acid—Rash—Doxorubicin—ovarian cancer	0.00011	0.00119	CcSEcCtD
Salicylic acid—Dermatitis—Doxorubicin—ovarian cancer	0.00011	0.00119	CcSEcCtD
Salicylic acid—Headache—Doxorubicin—ovarian cancer	0.000109	0.00118	CcSEcCtD
Salicylic acid—Nausea—Doxorubicin—ovarian cancer	0.000103	0.00112	CcSEcCtD
Salicylic acid—SLC16A1—Hemostasis—MAPK3—ovarian cancer	1.8e-05	0.000641	CbGpPWpGaD
Salicylic acid—ALB—Selenium Micronutrient Network—IL6—ovarian cancer	1.8e-05	0.000641	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—ABCB1—ovarian cancer	1.79e-05	0.000637	CbGpPWpGaD
Salicylic acid—AKR1C1—Metabolism—PIK3CB—ovarian cancer	1.78e-05	0.000631	CbGpPWpGaD
Salicylic acid—PTGS2—Spinal Cord Injury—IL6—ovarian cancer	1.76e-05	0.000626	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—TYMS—ovarian cancer	1.76e-05	0.000626	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	1.73e-05	0.000616	CbGpPWpGaD
Salicylic acid—SLC16A1—Hemostasis—MAPK1—ovarian cancer	1.72e-05	0.00061	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—PIK3CD—ovarian cancer	1.7e-05	0.000605	CbGpPWpGaD
Salicylic acid—ALB—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	1.69e-05	0.000602	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—CYTB—ovarian cancer	1.69e-05	0.0006	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.67e-05	0.000595	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—HDAC6—ovarian cancer	1.65e-05	0.000586	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.65e-05	0.000586	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	1.64e-05	0.000583	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—STAT3—ovarian cancer	1.64e-05	0.000582	CbGpPWpGaD
Salicylic acid—ALB—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	1.64e-05	0.000581	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—NRAS—ovarian cancer	1.64e-05	0.000581	CbGpPWpGaD
Salicylic acid—SLC16A1—Hemostasis—KRAS—ovarian cancer	1.62e-05	0.000576	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—SOD1—ovarian cancer	1.62e-05	0.000574	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—PPP2R1A—ovarian cancer	1.61e-05	0.000571	CbGpPWpGaD
Salicylic acid—ALB—Platelet activation, signaling and aggregation—PIK3CB—ovarian cancer	1.6e-05	0.000568	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	1.6e-05	0.000567	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	1.6e-05	0.000567	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—MAPK3—ovarian cancer	1.57e-05	0.000556	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	1.56e-05	0.000554	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	1.56e-05	0.000554	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—YAP1—ovarian cancer	1.54e-05	0.000547	CbGpPWpGaD
Salicylic acid—AKR1C1—Metabolism—PTEN—ovarian cancer	1.54e-05	0.000545	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.52e-05	0.000542	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—MYC—ovarian cancer	1.52e-05	0.000541	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—ERBB2—ovarian cancer	1.51e-05	0.000535	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—MAPK1—ovarian cancer	1.49e-05	0.000529	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—EGFR—ovarian cancer	1.49e-05	0.000529	CbGpPWpGaD
Salicylic acid—SLC16A1—Hemostasis—PIK3CA—ovarian cancer	1.49e-05	0.000529	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—MTOR—ovarian cancer	1.49e-05	0.000528	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—PIK3CB—ovarian cancer	1.49e-05	0.000528	CbGpPWpGaD
Salicylic acid—ABCB1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	1.48e-05	0.000527	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	1.48e-05	0.000527	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—CYTB—ovarian cancer	1.48e-05	0.000525	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	1.48e-05	0.000525	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—PPP1CC—ovarian cancer	1.48e-05	0.000524	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—BRIP1—ovarian cancer	1.48e-05	0.000524	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	1.47e-05	0.000524	CbGpPWpGaD
Salicylic acid—ALB—Platelet activation, signaling and aggregation—IL2—ovarian cancer	1.47e-05	0.000522	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	1.45e-05	0.000514	CbGpPWpGaD
Salicylic acid—SLC16A1—Hemostasis—TP53—ovarian cancer	1.44e-05	0.000512	CbGpPWpGaD
Salicylic acid—ABCB1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	1.43e-05	0.000509	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—XIAP—ovarian cancer	1.43e-05	0.000508	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—CXCL8—ovarian cancer	1.43e-05	0.000507	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—CAV1—ovarian cancer	1.42e-05	0.000504	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	1.41e-05	0.000501	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—KRAS—ovarian cancer	1.41e-05	0.0005	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	1.4e-05	0.000496	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—SMARCA4—ovarian cancer	1.39e-05	0.000495	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—CDKN1B—ovarian cancer	1.39e-05	0.000495	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—CYTB—ovarian cancer	1.38e-05	0.000491	CbGpPWpGaD
Salicylic acid—SLC16A1—Hemostasis—HRAS—ovarian cancer	1.38e-05	0.000489	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—CASP3—ovarian cancer	1.37e-05	0.000485	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—IL2—ovarian cancer	1.36e-05	0.000485	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—EREG—ovarian cancer	1.36e-05	0.000483	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	1.36e-05	0.000483	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	1.35e-05	0.000481	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.35e-05	0.00048	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.34e-05	0.000476	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—CCND1—ovarian cancer	1.33e-05	0.000472	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.33e-05	0.000472	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—CTNNB1—ovarian cancer	1.32e-05	0.000468	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	1.31e-05	0.000465	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—PIK3CA—ovarian cancer	1.29e-05	0.000459	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—PIK3CG—ovarian cancer	1.29e-05	0.000459	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—PPP1CC—ovarian cancer	1.29e-05	0.000459	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—BRIP1—ovarian cancer	1.29e-05	0.000459	CbGpPWpGaD
Salicylic acid—ALB—Transmembrane transport of small molecules—ABCB1—ovarian cancer	1.29e-05	0.000459	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—MMP9—ovarian cancer	1.29e-05	0.000459	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—PTEN—ovarian cancer	1.28e-05	0.000456	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—FASN—ovarian cancer	1.26e-05	0.000446	CbGpPWpGaD
Salicylic acid—ALB—Platelet activation, signaling and aggregation—VEGFA—ovarian cancer	1.25e-05	0.000443	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—SLC5A5—ovarian cancer	1.24e-05	0.000439	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	1.23e-05	0.000437	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—YAP1—ovarian cancer	1.22e-05	0.000435	CbGpPWpGaD
Salicylic acid—SLC16A1—Hemostasis—AKT1—ovarian cancer	1.22e-05	0.000432	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.21e-05	0.00043	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—BRIP1—ovarian cancer	1.21e-05	0.000429	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PPP1CC—ovarian cancer	1.21e-05	0.000429	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—HRAS—ovarian cancer	1.2e-05	0.000425	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—SLC2A1—ovarian cancer	1.19e-05	0.000424	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—FASN—ovarian cancer	1.19e-05	0.000423	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—PARP1—ovarian cancer	1.19e-05	0.000421	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—CAV1—ovarian cancer	1.18e-05	0.00042	CbGpPWpGaD
Salicylic acid—ALB—Platelet activation, signaling and aggregation—MAPK3—ovarian cancer	1.18e-05	0.000419	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.17e-05	0.000415	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	1.16e-05	0.000413	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—VEGFA—ovarian cancer	1.16e-05	0.000412	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—STAT3—ovarian cancer	1.15e-05	0.000408	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—NRAS—ovarian cancer	1.15e-05	0.000407	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—IL6—ovarian cancer	1.15e-05	0.000407	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—CYP1B1—ovarian cancer	1.14e-05	0.000406	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—PIK3CD—ovarian cancer	1.14e-05	0.000404	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—SLC2A1—ovarian cancer	1.13e-05	0.000402	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	1.13e-05	0.000402	CbGpPWpGaD
Salicylic acid—ALB—Platelet activation, signaling and aggregation—MAPK1—ovarian cancer	1.12e-05	0.000399	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	1.11e-05	0.000393	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	1.11e-05	0.000393	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	1.11e-05	0.000393	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—MAPK3—ovarian cancer	1.1e-05	0.00039	CbGpPWpGaD
Salicylic acid—AKR1C1—Metabolism—PIK3CA—ovarian cancer	1.08e-05	0.000385	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—PIK3CG—ovarian cancer	1.08e-05	0.000382	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.08e-05	0.000382	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—MYC—ovarian cancer	1.07e-05	0.000379	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.06e-05	0.000378	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—AKT1—ovarian cancer	1.06e-05	0.000375	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	1.04e-05	0.000371	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—MAPK1—ovarian cancer	1.04e-05	0.000371	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—EGFR—ovarian cancer	1.04e-05	0.000371	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—PPP2R1A—ovarian cancer	1.01e-05	0.00036	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.01e-05	0.000359	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—FASN—ovarian cancer	9.97e-06	0.000354	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—PIK3CB—ovarian cancer	9.91e-06	0.000352	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—YAP1—ovarian cancer	9.9e-06	0.000352	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—KRAS—ovarian cancer	9.86e-06	0.00035	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—SLC5A5—ovarian cancer	9.81e-06	0.000348	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	9.79e-06	0.000348	CbGpPWpGaD
Salicylic acid—ALB—Platelet activation, signaling and aggregation—PIK3CA—ovarian cancer	9.75e-06	0.000346	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—PPP2R1A—ovarian cancer	9.62e-06	0.000342	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	9.6e-06	0.000341	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—SLC2A1—ovarian cancer	9.47e-06	0.000336	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—PIK3CD—ovarian cancer	9.46e-06	0.000336	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—ABCB1—ovarian cancer	9.42e-06	0.000335	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	9.29e-06	0.00033	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	9.28e-06	0.000329	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—TYMS—ovarian cancer	9.25e-06	0.000329	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—CYP1B1—ovarian cancer	9.08e-06	0.000323	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—PIK3CA—ovarian cancer	9.06e-06	0.000322	CbGpPWpGaD
Salicylic acid—AKR1C1—Metabolism—AKT1—ovarian cancer	8.85e-06	0.000314	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	8.8e-06	0.000313	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—TP53—ovarian cancer	8.76e-06	0.000311	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—YAP1—ovarian cancer	8.67e-06	0.000308	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	8.61e-06	0.000306	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—PTEN—ovarian cancer	8.56e-06	0.000304	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—HRAS—ovarian cancer	8.38e-06	0.000298	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—PIK3CB—ovarian cancer	8.24e-06	0.000293	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—YAP1—ovarian cancer	8.1e-06	0.000288	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—FASN—ovarian cancer	8.07e-06	0.000287	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—PPP2R1A—ovarian cancer	8.05e-06	0.000286	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—IL6—ovarian cancer	8.02e-06	0.000285	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	8.02e-06	0.000285	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	8.02e-06	0.000285	CbGpPWpGaD
Salicylic acid—ALB—Platelet activation, signaling and aggregation—AKT1—ovarian cancer	7.96e-06	0.000283	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—SLC5A5—ovarian cancer	7.94e-06	0.000282	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	7.84e-06	0.000279	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—SLC2A1—ovarian cancer	7.66e-06	0.000272	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—TERT—ovarian cancer	7.64e-06	0.000271	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—IL2—ovarian cancer	7.57e-06	0.000269	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	7.5e-06	0.000267	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—ABCB1—ovarian cancer	7.48e-06	0.000266	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—CAV1—ovarian cancer	7.46e-06	0.000265	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—AKT1—ovarian cancer	7.4e-06	0.000263	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—CYP1B1—ovarian cancer	7.35e-06	0.000261	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—TYMS—ovarian cancer	7.35e-06	0.000261	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	7.12e-06	0.000253	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—FASN—ovarian cancer	7.07e-06	0.000251	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—CAV1—ovarian cancer	7.07e-06	0.000251	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	7.05e-06	0.00025	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—SLC5A5—ovarian cancer	6.95e-06	0.000247	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—PIK3CG—ovarian cancer	6.79e-06	0.000241	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—SLC2A1—ovarian cancer	6.72e-06	0.000239	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—IL6ST—ovarian cancer	6.7e-06	0.000238	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—FASN—ovarian cancer	6.6e-06	0.000235	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—PPP2R1A—ovarian cancer	6.52e-06	0.000231	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—SLC5A5—ovarian cancer	6.5e-06	0.000231	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	6.48e-06	0.00023	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—CYP1B1—ovarian cancer	6.44e-06	0.000229	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—APC—ovarian cancer	6.44e-06	0.000229	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—VEGFA—ovarian cancer	6.43e-06	0.000229	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—NRAS—ovarian cancer	6.35e-06	0.000226	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—SLC2A1—ovarian cancer	6.27e-06	0.000223	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	6.14e-06	0.000218	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—MAPK3—ovarian cancer	6.09e-06	0.000216	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—ABCB1—ovarian cancer	6.05e-06	0.000215	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—PIK3CA—ovarian cancer	6.04e-06	0.000215	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—CYP1B1—ovarian cancer	6.01e-06	0.000214	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—PIK3CD—ovarian cancer	5.97e-06	0.000212	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—TYMS—ovarian cancer	5.94e-06	0.000211	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—CAV1—ovarian cancer	5.92e-06	0.00021	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—MAPK1—ovarian cancer	5.79e-06	0.000206	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—PPP2R1A—ovarian cancer	5.71e-06	0.000203	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—PIK3CD—ovarian cancer	5.66e-06	0.000201	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	5.65e-06	0.000201	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—KRAS—ovarian cancer	5.47e-06	0.000194	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—PIK3CG—ovarian cancer	5.39e-06	0.000192	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	5.33e-06	0.000189	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	5.31e-06	0.000189	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—TYMS—ovarian cancer	5.21e-06	0.000185	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—PIK3CB—ovarian cancer	5.2e-06	0.000185	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—PIK3CA—ovarian cancer	5.03e-06	0.000179	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—ERBB2—ovarian cancer	5e-06	0.000178	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—ABCB1—ovarian cancer	4.95e-06	0.000176	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—AKT1—ovarian cancer	4.93e-06	0.000175	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—MTOR—ovarian cancer	4.93e-06	0.000175	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—PIK3CB—ovarian cancer	4.93e-06	0.000175	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—TYMS—ovarian cancer	4.86e-06	0.000173	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—TP53—ovarian cancer	4.86e-06	0.000173	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—CAV1—ovarian cancer	4.79e-06	0.00017	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—PIK3CD—ovarian cancer	4.74e-06	0.000168	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—HRAS—ovarian cancer	4.65e-06	0.000165	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—CDKN1B—ovarian cancer	4.63e-06	0.000164	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.57e-06	0.000163	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—PTEN—ovarian cancer	4.5e-06	0.00016	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—CTNNB1—ovarian cancer	4.37e-06	0.000155	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—PIK3CG—ovarian cancer	4.36e-06	0.000155	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—PTEN—ovarian cancer	4.26e-06	0.000151	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—CAV1—ovarian cancer	4.2e-06	0.000149	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—PIK3CB—ovarian cancer	4.13e-06	0.000147	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—AKT1—ovarian cancer	4.11e-06	0.000146	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—CAV1—ovarian cancer	3.92e-06	0.000139	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—PIK3CD—ovarian cancer	3.83e-06	0.000136	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—PIK3CG—ovarian cancer	3.82e-06	0.000136	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—STAT3—ovarian cancer	3.81e-06	0.000135	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—NRAS—ovarian cancer	3.8e-06	0.000135	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	3.74e-06	0.000133	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—MAPK3—ovarian cancer	3.64e-06	0.000129	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PIK3CG—ovarian cancer	3.57e-06	0.000127	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—PTEN—ovarian cancer	3.57e-06	0.000127	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—MYC—ovarian cancer	3.54e-06	0.000126	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—MAPK1—ovarian cancer	3.47e-06	0.000123	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—EGFR—ovarian cancer	3.46e-06	0.000123	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—PIK3CD—ovarian cancer	3.36e-06	0.000119	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—PIK3CB—ovarian cancer	3.34e-06	0.000119	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—KRAS—ovarian cancer	3.27e-06	0.000116	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—PIK3CA—ovarian cancer	3.17e-06	0.000113	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PIK3CD—ovarian cancer	3.14e-06	0.000111	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—PIK3CA—ovarian cancer	3.01e-06	0.000107	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—PIK3CB—ovarian cancer	2.93e-06	0.000104	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—PTEN—ovarian cancer	2.89e-06	0.000103	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—HRAS—ovarian cancer	2.78e-06	9.88e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PIK3CB—ovarian cancer	2.74e-06	9.72e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—IL6—ovarian cancer	2.66e-06	9.46e-05	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—AKT1—ovarian cancer	2.59e-06	9.21e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—PTEN—ovarian cancer	2.53e-06	8.99e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—PIK3CA—ovarian cancer	2.52e-06	8.95e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—AKT1—ovarian cancer	2.46e-06	8.73e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PTEN—ovarian cancer	2.36e-06	8.4e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—AKT1—ovarian cancer	2.06e-06	7.31e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—PIK3CA—ovarian cancer	2.04e-06	7.24e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—PIK3CA—ovarian cancer	1.79e-06	6.34e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PIK3CA—ovarian cancer	1.67e-06	5.92e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—AKT1—ovarian cancer	1.66e-06	5.91e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—AKT1—ovarian cancer	1.46e-06	5.18e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—AKT1—ovarian cancer	1.36e-06	4.84e-05	CbGpPWpGaD
